IBSA USA
Jake Seaman is an experienced sales professional specializing in endocrinology and pain management, currently serving as a Sales Specialist at IBSA USA since October 2020 in the Greater Richmond Area. Previous roles include Associate Sales Consultant for DePuy Synthes, focusing on joint reconstruction and orthopedic trauma products from August 2018 to March 2020, and Certified Medical Assistant at OrthoVirginia from August 2015 to August 2018. Jake also served as an Emergency Department Scribe at VCU Health for nearly a year and held the position of Enrollment Student Ambassador at the University of Lynchburg during undergraduate studies. Jake earned a Bachelor of Science degree in Biology and Spanish from the University of Lynchburg in 2014.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.